CANVSGDTC• 6 Months (Normalized)
CAN vs GDTC (Canaan Inc. vs CytoMed Therapeutics Limited)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CAN Performance $0.34
-29.79%
Canaan Inc.
Normalized Baseline0.00%
GDTC Performance $0.78
-25.52%
CytoMed Therapeutics Limited
Normalized Baseline0.00%
Alpha Spread Margin GDTC LEADS
-4.27%
GDTC outperforming by 4.27%
CANGDTC
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CAN GDTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | CAN Price | CAN Gain (%) | GDTC Price | GDTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.34 | -29.79% | $0.78 | -25.52% | -4.27% |
| Sep 10, 2026 | $0.31 | -35.62% | $0.81 | -22.86% | -12.76% |
| Sep 09, 2026 | $0.32 | -34.17% | $0.80 | -24.29% | -9.88% |
| Sep 08, 2026 | $0.32 | -32.71% | $0.87 | -17.14% | -15.57% |
| Sep 04, 2026 | $0.36 | -25.00% | $0.86 | -18.00% | -7.00% |
| Sep 03, 2026 | $0.39 | -18.12% | $0.88 | -16.19% | -1.93% |
| Sep 02, 2026 | $0.31 | -35.83% | $0.88 | -16.19% | -19.64% |
| Sep 01, 2026 | $0.32 | -33.75% | $0.91 | -13.43% | -20.32% |
| Aug 31, 2026 | $0.37 | -23.96% | $0.91 | -13.43% | -10.53% |
| Aug 28, 2026 | $0.38 | -20.83% | $0.92 | -12.38% | -8.45% |
| Aug 27, 2026 | $0.44 | -7.71% | $0.95 | -9.52% | +1.81% |
| Aug 26, 2026 | $0.40 | -17.08% | $1.00 | -5.05% | -12.03% |
| Aug 25, 2026 | $0.42 | -13.13% | $0.94 | -10.95% | -2.18% |
| Aug 24, 2026 | $0.36 | -25.00% | $1.00 | -4.76% | -20.24% |
| Aug 21, 2026 | $0.36 | -26.04% | $1.03 | -1.90% | -24.14% |
Page 1 of 9